VCP
PFE icon

Vista Capital Partners’s Pfizer PFE Stock Holding History

Vista Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Sell
9,292
-26
-0.3% -$680 0.02% 158
2026
Q1 		$262K Buy
+9,318
New +$248K 0.03% 132
2023
Q3 		– Sell
-5,739
Closed -$211K – 85
2023
Q2 		$211K Buy
+5,739
New +$223K 0.03% 86

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Vista Capital Partners's PFE Position: Q2 2026 in Review

Vista Capital Partners reduced its Pfizer (PFE) stake by 0.28% in Q2 2026, selling an estimated $680 and leaving 9,292 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #158.

Vista Capital Partners first reported a position in PFE in Q2 2023 and has held it in 3 quarters since. The position peaked at $262K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vista Capital Partners held 9,292 shares of Pfizer worth $224K as of Q2 2026.
  • Vista Capital Partners sold 26 Pfizer shares in Q2 2026, an estimated $680.
  • Pfizer made up 0.02% of Vista Capital Partners's portfolio in Q2 2026, its #158 holding.
  • Vista Capital Partners first reported a position in Pfizer in Q2 2023 and has held it in 3 quarters since.
  • Vista Capital Partners's Pfizer position peaked at $262K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vista Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.